Endurant Capital Management LP Bio Rad Laboratories, Inc. Transaction History

Endurant Capital Management LP

$0
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $2.22 Million - $2.66 Million	5,292 Added 135.94%	9,185 $4.4 Million
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $1.09 Million - $1.41 Million	-3,091 Reduced 44.26%	3,893 $1.64 Million
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $3.73 Million - $5.09 Million	-9,044 Reduced 56.43%	6,984 $2.91 Million
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $520,701 - $670,610	-1,123 Reduced 6.55%	16,028 $7.93 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $1.37 Million - $1.92 Million	2,612 Added 17.97%	17,151 $9.66 Million
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $2.65 Million - $2.97 Million	-3,733 Reduced 20.43%	14,539 $11 Million
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $4.24 Million - $5.33 Million	6,452 Added 54.59%	18,272 $13.6 Million
Q2 2021 Aug 16, 2021	SELL	$576.64 - $649.04 $1.71 Million - $1.92 Million	-2,964 Reduced 20.05%	11,820 $7.62 Million
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $8.09 Million - $9.79 Million	14,784 New	14,784 $8.44 Million
Q4 2020 Feb 16, 2021	SELL	$510.68 - $643.45 $2 Million - $2.52 Million	-3,916 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$454.43 - $535.6 $186,770 - $220,131	411 Added 11.73%	3,916 $2.02 Million
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $1.17 Million - $1.73 Million	3,505 New	3,505 $1.58 Million
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $2.21 Million - $2.59 Million	-6,910 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $966,946 - $1.1 Million	3,175 Added 85.01%	6,910 $2.3 Million
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $1.07 Million - $1.17 Million	3,735 New	3,735 $1.17 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.19B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Account